Health status of UK patients with active tuberculosis
METHODS: Questionnaires were administered prospectively to patients at three clinics in London at diagnosis and 2 months into therapy. We assessed generic health-related quality of life (Short Form 36 [SF-36] and EQ-5D) and psychological burden (State-Trait Anxiety Short-Form, Center for Epidemiologic Studies Depression Scale, worry items).
RESULTS: Of the 61 participants (response rate 94%), 89% were non-UK born, 67% had pulmonary TB and 38% were aged 30–45 years. At diagnosis, scores for all eight SF-36 dimensions were significantly worse than UK general population norm scores. At follow-up, scores had improved significantly (P < 0.01), except for physical functioning and general health perception, but remained below the UK norm, except for vitality and mental health. Respondents' mean anxiety and depression scores were high at diagnosis (48 and 22, respectively), and anxiety scores remained high at follow-up. Worries most frequently reported concerned patients' own health (92%) and that of their family (82%).
CONCLUSIONS: TB patients suffer from significantly diminished health-related quality of life at diagnosis. Although treatment significantly improved patients' health status within 2 months, scores for many domains remain below UK norm scores. This emphasises the importance of a holistic approach to care and should inform the evaluation of future interventions.
Document Type: Regular Paper
Affiliations: 1: Department of Respiratory and Systemic Infections, Centre for Infections, Health Protection Agency, London, UK 2: Department of Respiratory Medicine, Royal Free Hospital, London, UK 3: Department of Social Medicine, University of Amsterdam, Amsterdam, The Netherlands 4: Department of Respiratory Medicine, North Middlesex University Hospital, London, UK 5: Barnet and Chase Farm Hospitals National Health Service Trust, London, UK 6: Royal Free Hospital, North Central London TB Service, London, UK 7: London Regional Epidemiology Unit, Health Protection Agency, London, UK; and St Georges Hospital Medical School, London, UK 8: Department of Respiratory and Systemic Infections, Centre for Infections, Health Protection Agency, London, UK; and School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
Publication date: March 1, 2010
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content